Safety, Ethics and Regulations

Phuc Van Pham received his Ph.D. in Human Physiology from Vietnam National University, Ho Chi Minh City, Vietnam. He is currently a Professor of Biology at University of Science (Vietnam National University Ho Chi Minh city, Vietnam); and Director of the Stem Cell Institute; Vice-Director, Key Laboratory of Cancer Research. He is a longstanding lecturer and translational scientist at the University, and is a member of several societies and journal editorial boards focused on stem cells. Dr. Pham and his colleagues have established one of the first multidisciplinary stem cell center in Vietnam, and he has successfully launched an array of technologies in stem cell isolations. His research interests include stem cell isolation, stem cell therapy, mesenchymal stem cells, cancer stem cells, immunotherapy and regenerative medicine and he has published extensively in these areas. After many years of experience as an embryologist, cell biologist, and molecular biologist, c ollaborating with leading researchers in Singapore, Japan, and the United States, Dr. Pham is a student again, keen to reach beyond the traditional boundaries of biology. Achim Rosemann is a Research Fellow in the Centre for Education Studies at the Faculty of the Social Sciences, University of Warwick. His research addresses the social, political, regulatory and economic dimensions of life and health science research, with a regional focus on developments in China and East Asia. He has received his PhD in Social Anthropology from the University of Sussex, with a specialization in Science and Technology Studies and Medical Anthropology. He is also a research associate at the Centre for Bionetworking at the University of Sussex.

Part I. Safety .- Chapter 1: The safety of allogeneic stem cell transplantation .- Chapter 2: Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-related Chronic Neurodegenerative Diseases .- Chapter 3: IClinical safety and applications of stem cell gene therapy .- Chapter 4: The safety of non-expanded multipotential stromal cell therapies.- Part II: Ethics and Regulations .- Chapter 5: A Normative Case for the Patentability of Human Embryonic Stem Cell Technologies .- Chapter 6. Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions .- Chapter 7. New Regulatory Pathways for Stem Cell-Based Therapies: Comparison and Critique of Potential Models.- Chapter 8: Travelling cells - Harmonised European Regualtion and the BAMI stem cell trial.- Chapter 9: Oversight and Evidence in Stem Cell Innovation: An Examination of International Guidelines.- Chapter 10: The regulation of clinical stem cell research in China .- Chapter 11: Gov